TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral ...

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.

Fridays weight loss is a telehealth provider that offers access to popular GLP-1 medications, including compounded versions ...

Eli Lilly, the drugmaker with two weight-loss bestsellers, just got its first dose of healthy skeptism during a time when the ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Janelle Rohner claims she still followed her diet plan, noting GLP-1 weight loss drugs "don’t change your lifestyle overnight ...

Home > Pressemitteilung: GIP Receptor: Activation and Blockade ...

BORDERLINE alcoholic’ Shane Harding claims King Kong weight loss jab Mounjaro helped her shed six stone by curbing her ...